EUVIMEDEUVIMED entdecken
Crossref

Low HDL Cholesterol is Associated with Reduced Bleeding Risk in Patients who Underwent PCI: Findings from the PRACTICE Study

Ying-Ying Zheng, Ting-Ting Wu, Xian-Geng Hou, Yi Yang, Hai-Tao Yang, Ying Pan, Wen-Juan Xiu, Xiang Ma iD, Yi-Tong Ma, Xin-Ling Yang, Xiang Xie

Thrombosis and Haemostasis · 01.02.2025 · 125 (02) · 178-187

DOI: 10.1055/a-2104-1693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.02.2025. Verfasst von Ying-Ying Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, P.R. China. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Cholesterol, HDL, Coronary Artery Disease, Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Data Center of Management Science, National Natural Science Foundation of China - Peking University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We sought to examine the dose–response relationship between high-density lipoprotein cholesterol (HDL-C) and bleeds in coronary artery disease (CAD) patients who underwent percutaneous coronary intervention (PCI).

Methods

All the 15,250 participants were from the Personalized Antiplatelet Therapy According to CYP2C19 Genotype in Coronary Artery Disease (PRACTICE) study, which is a large, single-center, prospective cohort study based on case records and a follow-up registry performed in the First Affiliated Hospital of Xinjiang Medical University from December 2016 to October 2021. We divided all the patients into five groups according to their HDL-C levels: the ≤35 mg/dL group (n = 4,732), 35 to 45 mg/dL group (n = 6,049), 45 to 55 mg/dL group (n = 2,826), 55 and 65 mg/dL group (n = 1,117), and >65 mg/dL group (n = 526). The incidence of bleeds, mortality, ischemic events, and net adverse clinical events (NACEs) among the five groups was compared.

Results

A total of 713 bleeds, 1,180 ischemic events, 456 deaths, and 1,893 NACEs were recorded during the up to 60-month follow-up period. After adjusting for confounders, we observed a nonlinear relation for bleeds, with the highest risk at intermediate HDL-C levels (45–55 mg/dL). We also identified a dose–response relationship for ischemic events. A threshold value of HDL-C ≤35 mg/dL (adjusted hazard ratio = 0.560, 95% confidence interval: 0.360–0.872, p = 0.010) was associated with a decreased risk for bleeds in the multivariable Cox regression model. The results were consistent in multiple sensitivity analyses and propensity score-matching analysis.

Conclusion

In the present study, a nonlinear association was identified between HDL-C levels and bleeds in CAD patients who underwent PCI, with a higher risk at intermediate levels. However, further multicenter studies are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionCholesterol, HDLCoronary Artery DiseaseHemorrhageHumansFemaleMaleMiddle AgedAgedProspective StudiesRisk FactorsPlatelet Aggregation InhibitorsCytochrome P-450 CYP2C19Risk AssessmentChinaTreatment Outcome

Substanzen

Cholesterol, HDLPlatelet Aggregation InhibitorsCytochrome P-450 CYP2C19CYP2C19 protein, human

Autor:innen und Institutionen

  • Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, P.R. China.
  • Key Laboratory of High Incidence Disease Research in Xinjiang (Xinjiang Medical University), Ministry of Education, The People's Republic of China, Urumqi, P.R. China.

ORCID-Profile: Xiang Ma

Förderung

  • Data Center of Management Science, National Natural Science Foundation of China - Peking University

Zitieren

APA

Zheng, Y. Y., Wu, T. T., Hou, X. G., Yang, Y., Yang, H. T., Pan, Y., Xiu, W. J., Ma, X., Ma, Y. T., Yang, X. L., & Xie, X. (2025). Low HDL Cholesterol is Associated with Reduced Bleeding Risk in Patients who Underwent PCI: Findings from the PRACTICE Study. Thrombosis and Haemostasis, 125(02), 178-187. https://doi.org/10.1055/a-2104-1693

Vancouver

Zheng YY, Wu TT, Hou XG, Yang Y, Yang HT, Pan Y, et al. Low HDL Cholesterol is Associated with Reduced Bleeding Risk in Patients who Underwent PCI: Findings from the PRACTICE Study. Thrombosis and Haemostasis. 2025;125(02):178-187. doi:10.1055/a-2104-1693

BibTeX
@article{Zheng2025,
  author = {Zheng, Ying-Ying and Wu, Ting-Ting and Hou, Xian-Geng and Yang, Yi and Yang, Hai-Tao and Pan, Ying and Xiu, Wen-Juan and Ma, Xiang and Ma, Yi-Tong and Yang, Xin-Ling and Xie, Xiang},
  title = {Low HDL Cholesterol is Associated with Reduced Bleeding Risk in Patients who Underwent PCI: Findings from the PRACTICE Study},
  journal = {Thrombosis and Haemostasis},
  year = {2025},
  volume = {125},
  number = {02},
  pages = {178--187},
  doi = {10.1055/a-2104-1693}
}
Kostenlos starten →